baber/WOPTO huggingface dataset:
Patent CA-2529705-A1 (CA)
Title: Multiple inverters for motors
Inventor: KUMAR AJITH KUTTANNAIR
IPC: H02M7/48
Filed: 2004-06-09
Abstract: A non-highway vehicle including an engine, a DC power source (Vdc) driven by the engine and providing DC power via a DC bus (42, 44), a traction motor (46), a circuit for connection to the DC bus (42, 44) for providing power to the traction motor (46), and a controller. The circuit includes at least two inverters (40x, 40y) which share the power supplied to the traction motor (46). A first inverter (40x) connects between the DC bus (42, 44) and the traction motor (46) and a second inverter (40y) connects between the DC bus (42, 44) and the traction motor (46). The second inverter (40y) is in parallel connection with the first inverter (40x.) The controller (Figs. 2, 5) coordinates operation of the first and second inverter.
Patent CA-2529724-A1 (CA)
Title: In vitro fertilisation
Inventor: LINDENBERG SVEND
IPC: A61P15/00
Filed: 2003-06-17
Abstract: The present invention relates to a method and a system for producing a mammalian pre-embryo and a stem cell having a better quality than prior art methods. The system comprises means for obtaining a mammalian oocyte, and means for obtaining a mammalian spermatozoa, and an apparatus having at leas t two separate air-tight chambers, for which the oxygen tension of one chamber may be changed independent of the oxygen tension of the other chamber, said at least two separate air-tight chambers constitute a main chamber and at least one residence chamber. The method for in vitro producing a mammalian pre- embryo comprising the steps: a1) providing a mammalian oocyte, a2) providing a mammalian spermatozoa, b) culturing the oocyte and the spermatozoa, c) fertilizing the oocyte with the spermatozoa obtaining a fertilized oocyte, a nd d) allowing cell-division of the fertilized oocyte obtaining a multicellular pre-embryo wherein at least one of the steps a1) or a2) is conducted at an oxygen tension below 15%, or e) allowing cell-division of the fertilized oocyte obtaining a multicellular pre-embryo, wherein the culture is performe d at an oxygen tension allowing cultivation of the cells and wherein at least one of the steps comprises a change in the oxygen tension. Stem cells are produced from the multicellular pre-embryo.
Patent CA-2532051-A1 (CA)
Title: System, method, and computer program product for personal document management
Inventor: SHANNON ROBERT WILLIAM JOHN
IPC: G06Q10/00
Filed: 2004-07-08
Abstract: A system, method, and computer program product for allowing persons to scan and archive electronic versions of paper documents at any automated transaction machine. The electronic documents are then archived on a server in a central repository, preferably managed by the bank itself, and/or returned to the user via email or on a removable medium such as a disk, CDROM, or non-volatile memory. In this way, individuals can conveniently enjoy the benefits of electronic document archival, without the expense of purchasing the required hardware or software themselves. Other embodiments allow the user to retrieve and print archived documents.
Patent CA-2532384-A1 (CA)
Inventor: HEMLEY RUSSELL J
IPC: G11B27/11
Filed: 2004-07-14
Abstract: L'invention concerne un procédé pour améliorer la transparence optique d'un diamant produit par CVD, ce dernier étant un diamant produit par CVD à cristal simple, comprenant l'obtention pour le diamant d'une température de consigne d'au moins 1500 degrés C et d'une pression d'au moins 4.0 Gpa à l'extérieur de la phase stable du diamant.
Patent CA-2535424-A1 (CA)
Inventor: LOVE ROBERT T
IPC: H04L1/18
Filed: 2004-08-23
Abstract: During a random access communication opportunity (12), user equipment (20) utilizes either or both of an adaptive modulation and coding-based communication protocol (26) and an HARQ-based communication protocol (27) to achieve improved performance. This can avoid the need to establish dedicated channels (13) to support the required communications. In one embodiment, a plurality of adaptive modulation and coding-based communication protocols are provided with a given protocol being selected as a function of one or more governing criteria. For example, the protocol can be selected as a function of a quality condition of the communication path, as a function of a memory buffer, and so forth.
Patent CA-2535899-A1 (CA)
Inventor: GRILLI FRANCESCO
IPC: H04W72/00
Filed: 2004-08-20
Abstract: Transmission techniques are provided that improve service continuity and reduce interruptions in delivery of content that can be caused by transitions that occur when the User Equipment (UE) moves from one cell to the other, or when the delivery of content changes from a Point-to-Point (PTP) connection to a Point-to-Multipoint (PTM) connection in the same serving cell, and vice-versa. Such transmission techniques enable seamless delivery of content across cell borders and/or between different transmission schemes such as Point-to-Multipoint (PTM) and Point-to-Point (PTP). Mechanisms for adjusting different streams and for recovering content from each data block during such transitions are also provided so that data is not lost during a transition. In addition, mechanisms for realigning data during decoding at a receiving terminal are also provided.
Patent CA-2536651-A1 (CA)
Inventor: NEOGI AMAR N
IPC: C08B15/00
Filed: 2006-02-15
Abstract: The present application provides compositions comprising microcrystalline cellulose having a high hemicellulose level, a hemicellulose retention greater than 0.65 and a Leveling Off Degree Of Polymerization (LODP) of from about 195 to 240. The microcrystalline cellulose also has high brightness and a X-ray crystallinity index of at least 0.65.
Patent CA-2537248-A1 (CA)
Inventor: BONE PAUL ANTHONY
IPC: B65D25/46
Filed: 2003-08-21
Abstract: A container in the form of a petrol can (10, 100) comprises a body (11; 200, 201; 300, 301) having an inlet (30; 208; 309) and an outlet (20), a valve (3 9, 40, 45, 51) to control liquid flow through the outlet, and an actuator (19) controlling valve movement and operable at the exterior of the body. The bod y defines a sealed enclosure when the inlet is closed and the actuator (19) is in its non-operative position. A dispensing spout (27; 101; 206; 306) is non - removably attached at the outlet, and if this is flexible it can be flex so that part thereof is lockingly stored in a channel (25; 207; 307) of the bod y when the spout is not in use. The body can be in one-piece and define rear a nd top handles, or can have a inner part (200; 201) to which is secured an oute r body part (300; 301) which defines said handles.
Patent CA-2537281-A1 (CA)
Title: Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
Inventor: CALHOUN JASON
IPC: A61K31/496
Filed: 2004-09-07
Abstract: The present invention is directed to a method for treating bone or bone marrow infections, joint infection or infection of the tissues surrounding the joint by administration of the antibiotic tigecycline alone or in combination with a rifamycin antibiotic. In a preferred embodiment the bone or bone marrow infection causes osteomyelitis. In another embodiment the joint infection or infection of the tissues surrounding the joint causes septic arthritis. The invention is also directed to manufacture of a medicament for treatment of bone and/or bone marrow infections, or joint infections and/or infections in tissues surrounding the joint with tigecycline alone or in combination with rifampin.
Patent CA-2537404-A1 (CA)
Inventor: AUGUSTE MARIE-NOELLE
IPC: A61K31/55
Filed: 2006-02-24
Abstract: Forme cristalline .UPSILON.d du chlorhydrate de l'ivabradine de formule (I ): <IMG> caractérisée par son diagramme de diffraction X sur poudre.
Patent CA-2538498-A1 (CA)
Title: Backlight device and display device having the same
Inventor: KUMAMOTO YASUHIRO
IPC: H05B41/282
Filed: 2004-09-09
Abstract: A backlight device comprising a drive device and a backlight. The backlight comprises a first light source group and a second light source group. The drive device drives at least one fluorescent lamp in the first light source group in response to a first synchronous signal, and drives at least one fluorescent lamp in the second light source group in response to a second synchronous signal. The phase difference between the first synchronous signal and the second synchronous signal falls within a range of 60~ to 120~ or a range of 240~ to 300~.
Patent CA-2539287-A1 (CA)
Title: Content delivery apparatus, user terminal device, relief management method and computer program
Inventor: KURIHARA SHINICHI
IPC: G06Q30/06
Filed: 2006-03-10
Abstract: A content delivery apparatus, when a content delivery request is outputted from a user terminal device, encrypts the requested content with an encryption key, adds a view period to it to deliver it to a request source and delivers a viewing key in response to a view request from the user terminal device within the view period. A user relief management unit monitors failure information notifying, grasps a delivery disabled period from the failure information, specifies a delivery destination user for a content of which the view period is overlapped with the delivery disabled period and issues a relief right with a relief period specified thereto to the specified user. A contract period processing unit manages the relief right and permits viewing within the relief period set by the relief right when a view right based on the relief right is output from the user terminal device.
Patent CA-2541411-A1 (CA)
Inventor: LUIZZI JOSEPH M
IPC: A61L15/58
Filed: 2006-03-30
Abstract: An absorbent article including a liquid pervious cover, a liquid impermeable barrier, a body facing surface, an adhesive for securing the article to the body arranged on the body facing surface, and a removable release member for covering the adhesive prior to use, the release member being impervious to the migration of adhesive therethrough.
Patent CA-2542505-A1 (CA)
Inventor: MATSUOKA JUN
IPC: H03B5/04
Filed: 2006-04-07
Abstract: There is provided a high-stability piezoelectric oscillator. The high-stability piezoelectric oscillator includes an oscillating circuit unit that has a piezoelectric vibrator and oscillating circuit components, an inner oven that accommodates the oscillating circuit unit, an outer oven that accommodates the inner oven, and an outer metallic case that covers the outer even. Farther, airtightness is ensured inside and outside the outer metallic case. Furthermore, at least one of the outer oven and the inner oven is airtightly sealed.
Patent CA-2543511-A1 (CA)
Title: Earth boring apparatus for sinking shafts and method of excavating a shaft
Inventor: MEDD MORRIS J
IPC: E21B23/00
Filed: 2004-11-22
Abstract: An earth boring apparatus for sinking shafts and removing shaft material from the shaft, the apparatus having at least two decks; hydraulic means for allowing movement of the decks relative to one another; releasable anchoring means associated with the decks for engaging walls of the shaft to secure the apparatus in a stationary position; whereby the releasable anchoring means of one of the decks engages the wall while the releasable anchoring means of the other deck is released from the wall to allow motion of the other deck along the shaft, in cooperation with the hydraulic means. The apparatus also includes guide means for forcing a bucket for hoisting shaft material from the shaft along a predetermined path, and an in-stage cut-boom drill.
Patent CA-2544181-A1 (CA)
Inventor: CALLENTINE DONALD R
IPC: E05F15/16
Filed: 2006-04-18
Abstract: Methods and apparatus for reversing a drive motor for a barrier movement operator are disclosed. The operator senses the nature of a request for reversal and based on the nature of the sensed request performs one of a plurality of processes to reverse the motor.
Patent CA-2544497-A1 (CA)
Inventor: RAVISHANKAR HEMA
IPC: A61K9/24
Filed: 2004-09-15
Abstract: The invention relates to a multilayer pharmaceutical dosage form for the controlled release of active substances, containing: a) a core layer containing a substance that acts in a modulatory manner with regard to the release of active substances, optionally a neutral core and/or an active substance; b) an inner control layer that influences the release of the substance that acts in a modulatory manner and of the optionally contained active substance from the core layer, containing pharmaceutically useable polymers, waxes, resins and/or proteins; c) an active substance layer containing a pharmaceutical active substance and, optionally, a substance that acts in a modulatory manner; d) an outer control layer containing a (meth)acrylate copolymer or a mixture consisting of a number of (meth)acrylate copolymers comprised of 98 to 85 C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl esters of (meth)acrylic acid and 2 to 15% by weight of methacrylate monomers with a quaternary ammonium group in the alkyl radical and optionally containing pharmaceutically useable polymers that are insoluble in water, whereby the layers can contain, in addition and in a known manner, pharmaceutically conventional adjuvants.
Patent CA-2547666-A1 (CA)
Inventor: SHAHEEN KAMEL M
IPC: H04L45/74
Filed: 2004-11-30
Abstract: Method and apparatus for providing a solution to the handoff problem include s a handoff is triggered by the WLAN network 14 assuming that there is a real time session between PC 12 and a called party, shown at S1. WLAND network 14 communicates with IP network 18, shown at S2, the IP network 18 provides the two-way communication between the PC 12 and service server 22, shown at S3. Both the user PC 12 and UE 32 establish a connection with the network 23 at S4- S6. The user then decides to trigger a handoff from PC 12 to the UE 32 at S7 and communicates this handoff request to the WLAN network 14, which transmit s an SIP message through IP network 18 to service server 22. Service server 22 transmits an SIP 200 (OK) message to acknowledge the handoff (HO) message.</ SDOAB>
Patent CA-2548180-A1 (CA)
Inventor: EVANS ELIZABETH E
IPC: C12N5/06
Filed: 2004-12-06
Abstract: The invention provides in vitro and in vivo methods of killing cancer cells, including therapeutic methods in humans, and also provides antibodies specific for the cancer specific antigen C35, and polynucleotides encoding such antibodies, as well as therapeutic and diagnostic methods of using such antibodies.
Patent CA-2550606-A1 (CA)
Inventor: MATSUKAWA FUMIKAZU
IPC: H04Q3/42
Filed: 2006-06-16
Abstract: According to one embodiment, a server apparatus includes a memory which stores a management table indicating a correspondence relation between the terminal IDs and the connection IDs contained in a call information event and state information representing a call connection state between the plurality of telephone terminals, when the call connection is established between the plurality of telephone terminals, a determination unit to determine whether a call connection state between telephone terminals corresponding to the connection IDs is changed by referring to the management table based on the connection IDs contained in the call information event, when the call information event is received, and a controller which updates state information corresponding to the connection IDs in the management table, and performs a data communication connection between data terminals associated with the terminal IDs of the plurality of telephone terminals to be connected, based on the updated status information.
Patent CA-2551032-A1 (CA)
Title: All-optical, 3r regeneration using the sagnac and mach-zehnder versions of the terahertz optical asymmetric demultiplexer (toad)
Inventor: PRUCNAL PAUL R
IPC: H04B10/29
Filed: 2004-12-09
Abstract: A system and method for regenerating optical signals comprising a clock recovery circuit coupled to a transmission line, a first optical gating device having an input port coupled to the transmission line and a clock port coupled to the clock recovery circuit, and a second optical gating device having an input port coupled to a continuous wave (CW) laser and a clock port coupled to the output of the first optical gating device, wherein the optical gating devices may be terahertz optical asymmetric demultiplexers (TOADs).
Patent CA-2552693-A1 (CA)
Title: Novel fermentation process and uses therefor
Inventor: MCCAIG ROBERT
IPC: C12C11/00
Filed: 2006-07-18
Abstract: Disclosed is a method of producing a fermentation product using a natural protein concentrate in place of the protein derived from malted grains. The natural protein concentrate can be directly used, in addition with a carbohydrate source, to produce a wort suitable for fermentation, thus avoiding the malting and mash mixing steps in traditional brewing methods. The wort requires less yeast to initiate the fermentation process than in similar alcohol fermentations, and does not require the addition of yeast nutrients. The resulting fermentation product can be processed for bottling without the need for an intervening storage period. Conveniently, the natural protein concentrate can be derived from non-cereal sources such as peas, soy, rice potatoes and the like. Furthermore, using non-cereals sources permits the simplified production of a gluten-free fermentation product that can be used in preparing beverages consumable by persons suffering from gluten-intolerance.
Patent CA-2553198-A1 (CA)
Title: Cementitious products
Inventor: MAK SWEE LIANG
IPC: C04B22/04
Filed: 2004-01-15
Abstract: A method of manufacturing a porous cementitious product, which method comprises: forming a cementitious premix; casting the premix in a desired configuration; generating gas bubbles within the premix; and curing the premix, wherein gas bubbles are generated and/or collapsed at specific locations within the premix in order to produce a porosity profile along a cross-section of the product such that the product comprises a relatively low density core region and higher density outer regions.A method of manufacturing a porous cementitious product, which method comprises: forming a cementitious premix; casting the premix in a desired configuration; generating gas bubbles within the premix; and curing the premix, wherein gas bubbles are generated and/or collapsed at specific locations within the premix in order to produce a porosity profile along a cross-section of the product such that the product comprises a relatively low density core region and higher density outer regions.
Patent CA-2555228-A1 (CA)
Inventor: YOUNG STEVEN RANDAL
IPC: A61B18/00
Filed: 2004-09-14
Abstract: A method, device, and system for modifying or destroying selected tissue, by selecting an area of tissue for treatment, collecting the area between a plurality of energy transmitting elements, applying an electric current and/or electromagnetic radiation between the energy transmitting elements, and applying the electric current and/or electromagnetic radiation until, for example, the cells are modified or destroyed. Cooling may be applied to prevent unwanted modification. Conducting mediums may be applied to control tissue modification. Embodiments of the present invention may be used for treatment of fat cells, acne, lesions, tattoo removals etc.
Patent CA-2556517-A1 (CA)
Title: Packer having a seal and a support member for the seal
Inventor: GROSSER KAREN
IPC: E21B33/12
Filed: 2006-08-18
Abstract: A packer that is usable with a well includes a resilient seal element and a support member. The resilient seal element is adapted to radially expand in response to the longitudinal compression of the element. The support member is at least partially surrounded by the seal element and is adapted to radially expand with the seal element to support the element. The support sleeve is substantially harder than the seal element.
Patent CA-2559662-A1 (CA)
Inventor: STAHL CHAD H
IPC: C07K14/24
Filed: 2005-03-15
Abstract: The present invention relates to two recombinant colicin expression systems, one utilizing a yeast expression system that produces a protein that is inexpensive to purify, and the other utilizing a plasmid expression system to be used as a probiotic culture. The recombinant colicins provide effective alternatives to conventional antibiotics and may be used to improve the efficiency of pork production, and the safety of its products.
Patent CA-2559736-A1 (CA)
Inventor: HANANIA ELIE G
IPC: C12N13/00
Filed: 2005-03-14
Abstract: The invention provides methods for purifying one or more cells based on the level of one or more products secreted by the cells. In one embodiment, the method involves (a) contacting a plurality of cells immobilized in proximity to a capture matrix, the capture matrix capable of localizing a product secreted by one or more of the cells, with an agent that selectively binds to the product, the agent capable of generating a signal detectable as a property of light; (b) illuminating a population of the cells, the population contained in a frame; (c) detecting two or more properties of light directed from the frame, wherein a first property of light identifies substantially all cells of the population, and the second property of light identifies product localized to the capture matrix; (d) locating (i) substantially all cells of the population with reference to the detected first property of light, and (ii) one or more selected cells with reference to the detected second property of light, and (e) irradiating the non-selected cells, wherein each non-selected cell receives a substantially lethal dose of radiation, whereby one or more selected cells having a desired product secretion profile are purified.
Patent CA-2560522-A1 (CA)
Inventor: NYKJAER ANDERS
IPC: A61P39/00
Filed: 2004-03-25
Abstract: The present invention relates to the use of compounds for the manufacture of a medicament for the prophylaxis and/or treatment of induced cell toxicity, such as nephrotoxicity and ototoxicity, in particular where the cell toxicity is induced by a medical treatment. In a preferred embodiment the compounds have at least two nitrogen atoms, more preferably at least two amino groups. The compounds according to the invention are capable of blocking binding of cell toxic compounds to the megalin receptor, and thereby inhibiting uptake of the cell toxic compounds into cells. The invention further relates to novel compounds for use in said treatment, as well as a method for reducing the cell toxicity of cell toxic compounds, more particularly gentamicin.
Patent CA-2565911-A1 (CA)
Title: Solar cell with integrated protective diode
Inventor: STROBL GERHARD
IPC: H01L31/042
Filed: 2005-05-10
Abstract: The invention relates to a solar cell which comprises photoactive semiconductor layers extending between the front and the back contact, and an integrated protective diode (bypass diode). Said protective diode has a polarity opposite to that of the solar cell and is provided at its front with a p-conducting semiconductor layer, and the protective diode is connected to the front contact. The aim of the invention is to provide a highly stable protective diode and to prevent a migration of metal atoms. For this purpose, a tunnel diode (38) extends on the p-conducting semiconductor layer (36) of the protective diode (32), said tunnel diode being connected to the front contact (14) via an n+ layer.
Patent CA-2565999-A1 (CA)
Title: Products and processes for applying conditions to a lottery entry
Inventor: WALKER JAY S
IPC: G06Q50/34
Filed: 2005-05-11
Abstract: Products and processes are disclosed for receiving a lottery record associat ed with a sale of a lottery ticket. The lottery record includes a plurality of lottery numbers, and a condition for creating at least one entry that includes the lottery numbers in a lottery drawing. It is determined if the condition is satisfied. The at least one entry in the lottery drawing is created only if the condition satisfied.</SD OAB>